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Metastatic Uveal Malignant Melanoma: A Case Report
James Walter, MD, Rebecca Matro MD, and Daniel Quirk, MD, MPH

Case Report
A 77-year-old woman presented with a chief complaint of
one day history of severe, acute abdominal pain. The patient
described the pain as “intense,” non-radiating, and located
primarily in the left upper abdominal quadrant. The pain was
associated with nausea and multiple episodes of non-bilious,
non-bloody emesis. She denied melena and hematochezia. On
physical examination, her abdomen was soft and exquisitely
tender in the left upper quadrant and epigastric regions. Aside
from trace lower extremity edema, the remainder of her physical
examination was unremarkable. Laboratory results at the time
of admission were notable for: hemoglobin 10.8 g/dL, alkaline
phosphatase 459 U/L, aspartate transaminase 56 U/L, and
alanine transaminase 66 U/L.
The patient’s past medical history was significant for
hypertension, gastroesophageal reflux disease, papillary thyroid
carcinoma, and right eye uveal melanoma. The ocular melanoma
was treated 16 years ago with radioactive plaque followed by
transpupillary thermal therapy. The patient was diagnosed
with metastatic disease to her liver approximately 6 years prior
and she had received several rounds of hepatic radiation and
chemotherapeutic embolizations. The patient’s oncologist
closely monitored her for disease progression through regular
abdominal imaging studies.

Figure 1. Metastatic malignant melanoma lesions within
gastric body.

An esophagogastroduodenoscopy revealed a normal esophagus,
numerous hyperpigmented flat to slightly raised lesions
throughout the stomach, particularly in the proximal body and
fundus (Figures 1, 2), and a 2 mm lesion in the duodenal bulb
Histopathology and immunohistochemical staining of these
lesions confirmed metastatic malignant melanoma (Figure 3).

Discussion
The incidence of cutaneous malignant melanoma is rising at
a rate faster than that of any other malignancy.1 Melanoma is
notorious for its aggressive ability to metastasize to nearly every
part of the body, with the liver, lung, and bone being the most
common sites.2 With specific regards to uveal melanoma (UM),
it is the second most common form of melanoma. 3 Unlike
the cutaneous form, UM’s incidence rate has remained stable
over the years. UM can arise anywhere within the uveal tract
(iris, ciliary body and choroid) and spreads hematogenously.
Hematogenous spread is favored over lymphatic spread due to
the lack of sufficient lymphatic drainage.4,5
Melanoma’s particular affinity for metastasizing to the gastrointestinal (GI) tract has been well described in the literature. GI
involvement has been found in up to 60% of primary cutaneous
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Figure 2. Closer endoscopic view of a lesion.
malignant melanoma patients at autopsy and is commonly
associated with invasive visceral organ disease. Given the highly
vascularized nature of the small bowel, it is the most common
site of GI tract metastasis. Stomach involvement comprises
approximately 20% of GI tract metastasis cases Antemortum
diagnoses of GI metastasis are made in only 1% - 4% of patients
with malignant melanoma . Such a diagnosis can go clinically
undetected until years after the initial diagnosis.6-8
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Symptoms of GI melanoma metastasis tend to be inconspicuous
and nonspecific. Patients may report vague abdominal pain,
weight loss, nausea/vomiting, and/or malaise. Anemia may also
be seen as a result of slow, chronic blood loss from ulcerated lesion
sites giving rise to melena. Such symptoms should raise suspicion
in patients with a known history of melanoma. However, with a
median survival time of less than six months after confirmed GI
involvement, the prognosis is generally very poor.6
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Figure 3. Biopsy histopathology showing invasion of malignant
melanocytes into gastric mucosa.
Endoscopically, metastatic melanoma can be polypoid in nature,
is frequently ulcerated, and is either pigmented or amelaontic.8
Large polypoidal lesions can be obstructive in nature and can
act as lead points for intussusception. Submucosal nodules with
similar characteristics have also been seen.
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